MARKET

XBIO

XBIO

Xenetic
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.490
-0.060
-3.87%
Closed 16:00 09/18 EDT
OPEN
1.520
PREV CLOSE
1.550
HIGH
1.542
LOW
1.470
VOLUME
232.88K
TURNOVER
--
52 WEEK HIGH
54.60
52 WEEK LOW
1.350
MARKET CAP
5.58M
P/E (TTM)
-0.1200
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of XBIO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

EPS

XBIO News

  • 28 Healthcare Stocks Moving In Thursday's Pre-Market Session
  • Benzinga.6d ago
  • Xenetic Biosciences Shares Tick Higher On Volume As Traders Circulate US PTO Abstract For 'Method for treatment of primary hormone resistant endometrial and breast cancers'
  • Benzinga.09/10 14:11
  • Stocks That Hit 52-Week Lows On Wednesday
  • Benzinga.09/04 15:39
  • 26 Stocks Moving in Friday's Pre-Market Session
  • Benzinga.08/16 12:17

More

Industry

Biotechnology & Medical Research
-0.89%
Pharmaceuticals & Medical Research
-0.16%

Hot Stocks

Name
Price
%Change

About XBIO

Xenetic Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on discovery, research and development of biologic drugs and novel oncology therapeutics. The Company’s lead investigational product candidate is oncology therapeutic XBIO-101, which is used for the treatment of progestin - resistant endometrial cancer. The Company is currently conducting a Phase 2 trial for XBIO-101. The Company’s lead proprietary technology is PolyXen, which enables platform technology that can be applied to protein or peptide therapeutics using the natural polymer polysialic acid. The Company’s technology includes XBIO-101, PolyXen, OncoHist, ErepoXen and ImuXen. ErepoXen or polysialylated erythropoietin is an internal drug candidate which uses the company’s PolyXen platform technology for the treatment of anemia in chronic kidney disease (CKD) patients.
More

Webull offers Xenetic Biosciences Inc (XBIO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.